Defunct Company
Total Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
2,144
NCT01393665
Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 1996
Completion: Oct 31, 1997
NCT01393678
Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease
Phase: Phase 3
Start: Nov 30, 1997
Completion: May 31, 1998
NCT02019056
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
Start: Nov 30, 2010
Completion: Dec 31, 2014
NCT01373554
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease
Start: May 31, 2011
Completion: Oct 31, 2013
NCT01504646
Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
Phase: N/A
Role: Collaborator
Start: Jan 31, 2012
Completion: Aug 31, 2012
NCT02347319
To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease
Phase: Phase 4
Start: Apr 30, 2012
Completion: Jun 30, 2013
NCT01762397
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers
Phase: Phase 1
Start: Dec 31, 2012
Completion: Not specified
NCT01979926
Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis
Start: Nov 30, 2013
Completion: Mar 31, 2014
NCT02029313
Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
NCT02068339
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis
Start: Feb 28, 2014
Completion: Mar 31, 2016
NCT02342470
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Start: Nov 24, 2014
Completion: Dec 8, 2017
NCT02637310
Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis
Start: Dec 31, 2015
NCT04142749
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis
Start: Nov 15, 2019
Completion: Sep 26, 2022
NCT05864599
External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
Start: Jun 16, 2023
Completion: Jun 30, 2024